Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Cbd of Denver Inc

Healthcare US CBDD

0.0001USD
0.00(0%)

Last update at 2026-06-23T17:31:00Z

Day Range

0.00010.0001
LowHigh

52 Week Range

-0.0002
LowHigh

Fundamentals

  • Previous Close 0.0001
  • Market Cap1.07M
  • Volume16736638
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.29593M
  • Revenue TTM0.04M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.01M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -0.07840M 0.58M -3.25730M -0.30445M 1.03M
Minority interest - - - - -
Net income -0.07993M 0.58M -3.25100M -0.23600M 0.78M
Selling general administrative - - - - -
Selling and marketing expenses - - - - -
Gross profit 0.22M 0.17M -0.67000M 0.24M 1.41M
Reconciled depreciation - - - - -
Ebit 0.07M 0.70M -3.25400M -0.30000M 1.21M
Ebitda 0.09M 0.87M -3.02551M -0.06344M 1.21M
Depreciation and amortization 0.01M 0.17M 0.23M 0.24M 0.00258M
Non operating income net other - - - - -
Operating income 0.07M -0.26400M -2.74700M -0.32600M 1.21M
Other operating expenses 3.68M 3.25M 5.09M 23.18M 14.79M
Interest expense 0.15M 0.11M 0.00343M 0.00467M 0.18M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.00153M 0.00034M -0.00630M -0.06845M 0.25M
Total revenue 3.75M 2.98M 2.34M 22.85M 15.99M
Total operating expenses 0.14M 0.43M 2.08M 0.57M 0.20M
Cost of revenue 3.54M 2.82M 3.01M 22.61M 14.59M
Total other income expense net -0.15300M 0.85M -0.51030M 0.02M -0.17800M
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares - - - - -
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 0.04M 0.13M 0.03M 1.97M 2.74M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - 0.01M -
Total liab 1.38M 1.48M 2.00M 1.72M 1.94M
Total stockholder equity -1.33651M -1.35201M -1.96893M 0.25M 0.80M
Deferred long term liab - - - - -
Other current liab 0.19M 0.12M 0.09M 0.21M 0.02M
Common stock 0.08M 0.07M 0.06M 0.05M 0.05M
Capital stock - - - - -
Retained earnings -5.10950M -5.02957M -5.43148M -2.18007M -2.73440M
Other liab - - - - -
Good will - - - - -
Other assets - 0.00000M - - 0.00000M
Cash 0.04M 0.04M 0.03M 0.09M 0.08M
Cash and equivalents - - - - -
Total current liabilities 1.38M 1.48M 1.05M 1.20M 1.94M
Current deferred revenue - 0.00492M - - 0.31M
Net debt 1.03M 1.03M 0.92M 0.69M 0.17M
Short term debt 1.06M 1.06M - 0.26M 0.25M
Short long term debt - - - - -
Short long term debt total 1.06M 1.06M 0.95M 0.78M 0.25M
Other stockholder equity 3.76M 3.68M 3.53M 2.46M 3.44M
Property plant equipment - - - - -
Total current assets 0.04M 0.12M 0.03M 1.97M 2.65M
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments - - - - -
Net receivables 0.00564M 0.08M - 1.51M 2.15M
Long term debt - - - - -
Inventory - 0.00325M - 0.35M 0.42M
Accounts payable 0.12M 0.30M 0.96M 0.73M 1.36M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.06699M -0.06699M -0.12276M -0.08750M 0.04M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - -0.00000M - - 0.01M
Deferred long term asset charges - - - - -
Non current assets total - 0.01M - - 0.09M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments - - - - -
Change to liabilities - - - - -
Total cashflows from investing activities - 0.01M - - -0.01598M
Net borrowings - - - - -
Total cash from financing activities 0.09M 0.01M 0.73M 0.86M 0.00031M
Change to operating activities - - - - -
Net income -0.07993M 0.58M -3.25141M -0.23619M 0.78M
Change in cash -0.00143M 0.00850M -0.06347M 0.00886M 0.05M
Begin period cash flow 0.04M 0.03M 0.09M 0.08M 0.04M
End period cash flow 0.04M 0.04M 0.03M 0.09M 0.08M
Total cash from operating activities -0.08785M -0.03144M -0.75921M -0.72390M 0.06M
Issuance of capital stock - - - - -
Depreciation 0.01M - - - 0.00258M
Other cashflows from investing activities - -0.00000M - - -0.01598M
Dividends paid - - - - -
Change to inventory 0.00325M -0.00325M 0.35M -0.08185M -0.40566M
Change to account receivables 0.07M -0.07742M 1.51M -0.30959M -2.16747M
Sale purchase of stock - - - - -
Other cashflows from financing activities - 0.01M 0.84M 0.86M -0.01598M
Change to netincome - - - - -
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00001M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.01900M -0.71160M 1.99M -0.48931M -0.76360M
Stock based compensation - - - - -
Other non cash items - 0.10M 0.51M 0.00160M 0.04M
Free cash flow -0.08785M -0.03144M -0.75921M -0.72390M 0.06M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
CBDD
Cbd of Denver Inc		 - -% 0.0001 - - 25.27 -
ZTS
Zoetis Inc		 0.95 1.25% 76.84 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.42 1.37% 30.98 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 6.43 4.31% 155.71 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 0.48 1.12% 43.42 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

CBD of Denver Inc. engages in developing and commercializing cannabidiol (CBD) products. It is involved in the research, development, and distribution of premium hemp extract products. The company was formerly known as Verde Media Group, Inc. and changed its name to CBD of Denver Inc. in 2018. CBD of Denver Inc. is based in Centennial, Colorado. CBD of Denver Inc. operates as a subsidiary of Swiss Industry Ventures AG.

Cbd of Denver Inc

6436 South Quebec Street, Centennial, CO, United States, 80111

Key Executives

Name Title Year Born
Mr. William F. Veve Pres, Treasurer & Director NA
Mr. Marcel R. Gamma Chief Exec. Officer NA
Mr. Ethan Weyand Chief Financial Officer and Member of Advisory Board NA
Dr. Syed Hussain I. Abidi Ph.D. Director and Chief Exec. Officer of Verde Media Biotechnology Division NA
Mr. Frank Alfieri Chief Exec. Officer of the Diversified Agency Division NA
Brent LaGrange Head of Product Devel. & Sec. NA
Mr. William F. Veve President, Treasurer & Director NA
Dr. Syed Hussain I. Abidi Ph.D. Director and Chief Executive Officer of Verde Media Biotechnology Division NA
Brent LaGrange Head of Product Development & Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.